Professor Thomas Ristenpart wins Test of Time Award for privacy research

His award-winning paper was among the first to show how machine learning models can inadvertently leak sensitive information.

Around Cornell

Cats caught coronavirus from owners during early pandemic

New York City’s mostly indoor cats easily caught SARS-CoV-2 during the first wave of the COVID-19 epidemic – and most were asymptomatic and were likely infected by their owners.

AI-generated content a triple threat for Reddit moderators

Researchers at Cornell Tech and Cornell Bowers engaged directly with 15 content moderators on Reddit to see exactly how they try to preserve the news sharing site's humanity in an increasingly AI-infused world.

Cornell Tech hosts first-ever summit on disability, access, and AI

The summit brought together researchers, technologists, and community advocates to explore how disability and accessibility intersect with innovation.

Around Cornell

Galvanizing blood vessel cells to expand for organ transplantation

Scientists have discovered a method to induce enough human endothelial cells to replace damaged blood vessels or nourish organs for transplantation.

New faculty Andrew Owens makes AI that sees, hears, and feels

Andrew Owens wants computers to learn like humans do — by watching, listening, and feeling the world around them.

Around Cornell

Finance meets climate at Cornell panel

Finance can bridge the gap between climate science and business decision-making – and communication, innovation and education are critical, according to a panel of experts convened by the Cornell SC Johnson College of Business and the Cornell Atkinson Center for Sustainability during Climate Week 2025.

‘Ground truth’: Flood monitoring tool gives NYS residents a voice

The MyCoast New York app has already provided forecasters and emergency managers with a new understanding of flooding around the state, as sea levels rise and storms intensify. 

Research at Risk: Rooting out treatment-resistant prostate cancer

A federal stop-work order has threatened the progress a Weill Cornell Medicine researcher has made in understanding a lethal and treatment-resistant form of prostate cancer.